Nature’s Sunshine sales hit a record high, strong performance guidance, stock price up 4%

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) in Lehi, Utah, reported fourth-quarter results that exceeded analyst expectations, with adjusted earnings per share of $0.23, surpassing the market consensus of $0.21. Revenue increased 4.7% year-over-year to $123.8 million, beating analysts’ estimates of $118.82 million.

Following the announcement, the stock rose 4.5%.

The nutritional supplement manufacturer expects full-year revenue for fiscal 2026 to be between $500 million and $515 million, with a midpoint of $507.5 million, above the analyst consensus of $495 million. The company also projects full-year adjusted EBITDA to be between $50 million and $54 million.

Ken Romanzi, CEO of Nature’s Sunshine, said, “We closed the year with record sales and achieved our second-best quarter and largest fourth quarter ever, with sales and adjusted EBITDA growing 5% and 16%, respectively. Our digital strategy continues to perform strongly, driven by excellent customer acquisition.”

Adjusted EBITDA for the fourth quarter increased 16% to $11.9 million from $10.3 million in the same period last year. The company reported GAAP net income attributable to common shareholders of $4.1 million, or $0.23 per diluted share, compared to a net loss of $0.3 million, or a loss of $0.02 per share, in the prior year.

Digital channels performed particularly well, with new customer growth of 98% year-over-year in the fourth quarter, driving a 47% increase in digital business. This helped accelerate growth in North America to 6%. Revenue in Europe grew 18% to $25.2 million, while Asia declined 1% to $55.7 million.

Full-year net sales for fiscal 2025 increased 5.7% to $480.1 million, up from $454.4 million in 2024. The company ended the year with $93.9 million in cash and no debt.

This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.